nivolumab,ipilimumab
bms
['improve ', 'checkmate914', 'check,mate,914', 'nivo']
surprising data from #checkmate914 trial showing adjuvant ipi-nivo did not improve disease free survival for #kidneycancer. grateful as always for the patients who participated to help us learn in this massive trial. #esmo22 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe